BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10036642)

  • 1. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients.
    Matsukura M; Yamada H; Yudate T; Tezuka T; Chihara J
    J Clin Lab Immunol; 1996; 48(3):109-22. PubMed ID: 10036642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-induced changes of eosinophils in atopic dermatitis.
    Matsukura M; Yamada H; Yudate T; Tezuka T; Chihara J
    Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():51-4. PubMed ID: 9363926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomic analysis of peripheral blood eosinophils from healthy donors and atopic dermatitis patients with eosinophilia.
    Yoon SW; Kim TY; Sung MH; Kim CJ; Poo H
    Proteomics; 2005 May; 5(7):1987-95. PubMed ID: 15832365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
    Oldhoff JM; Darsow U; Werfel T; Katzer K; Wulf A; Laifaoui J; Hijnen DJ; Plötz S; Knol EF; Kapp A; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
    Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of TGF-beta 1 on cytokine-enhanced eosinophil survival].
    Atsuta J; Fujisawa T; Iguchi K; Terada A
    Arerugi; 1994 Sep; 43(9):1194-200. PubMed ID: 7802604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
    Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
    J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.
    Kagaya S; Hashida R; Ohkura N; Tsukada T; Sugita Y; Terakawa M; Tsujimoto G; Katsunuma T; Akasawa A; Matsumoto K; Saito H
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():35-44. PubMed ID: 15947483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
    Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
    J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronological analysis of eosinophil infiltration in mite-allergen induced dermatitis in atopic patients].
    Wakugawa M; Yamada N; Nakagawa H; Tamaki K
    Arerugi; 1995 Oct; 44(10):1199-206. PubMed ID: 8579481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
    Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
    Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The downregulation of Bcl-2 expression is necessary for theophylline-induced apoptosis of eosinophil.
    Chung IY; Nam-Kung EK; Lee NM; Chang HS; Kim DJ; Kim YH; Park CS
    Cell Immunol; 2000 Aug; 203(2):95-102. PubMed ID: 11006007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children.
    La Grutta S; Richiusa P; Pizzolanti G; Mattina A; Pajno GB; Citarrella R; Passalacqua G; Giordano C
    Allergy; 2005 Mar; 60(3):391-5. PubMed ID: 15679728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement.
    Ellis CN; Stevens SR; Blok BK; Taylor RS; Cooper KD
    Clin Immunol; 1999 Jul; 92(1):49-55. PubMed ID: 10413652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.